6 presentations were found matching your search word ST-S2 .

Strategic International Session (Symposium)2 (JSGS, JSGE)

November 5, 9:30–11:30, Room 9 (Portopia Hotel Main Building Kairaku 3)

Treatment strategy for locally advanced rectal cancer - LLND・NACRT・NAC・watch-and-wait

Time Slot for Each Speaker: (Time slots vary depending on presentations. Please prepare your presentation as below.)
  ST-S2-1_S : 20 min. for oral presentation, 5 min. for Q&A
  Other Presentations: 15 min. for oral presentation, 4 min. for Q&A
Discussion: Not to be held
Introductory Meeting: Not to be held
  • Chairperson:
    Tadahiko MasakiShimizugaoka Hospital
  • Chairperson:
    Shigeki YamaguchiDepartment of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University
  • Discussant:
    Tsuyoshi KonishiThe University of Texas MD Anderson Cancer Center
  • Discussant:
    Jeffrey MilsomWeill Cornell Medicine / New York Presbyterian Hospital

ST-S2-1_S
Treatment strategy for rectal cancer in MD Anderson Cancer Center

Tsuyoshi Konishi The University of Texas MD Anderson Cancer Center

ST-S2-2_S
Stratification for the risk of lateral lymph node metastasis of locally advanced rectal cancer

Atsushi Hamabe Department of Surgery, Surgical Oncology and Science, Sapporo Medical University

ST-S2-3_S
Short-term results of neoadjuvant radiation therapy for patients with locally advanced rectal cancer

Yusuke Suwa Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center

ST-S2-4_S
Personalized treatment strategies for locally advanced rectal cancer with using modified short-course preoperative chemoradiotherapy

Ryo Okamoto The Department of Surgery, Meiwa Hospital

ST-S2-5_S
Standardization of surgical treatment for advanced lower rectal cancer and efforts for future individualization

Hidekazu Takahashi Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine

ST-S2-6_S
Strategy based on neoadjuvant chemotherapy (NAC) for locally advanced rectal cancer and the new predictive marker for its response; the lymphocyte ratio before and after NAC.

Atsushi Ogura Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine

Page Top

Page Top